Paper40435239
Dual mechanism of inflammation sensing by the hematopoietic progenitor genome.
Tran VL and 9 others. Sci Adv, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Dual mechanism of inflammation sensing by the hematopoietic progenitor genome. Papers, record 40435239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40435239
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hematopoietic Stem Cells | Major topic |
| Inflammation | Major topic |
| Genome | Major topic |
| Animals | |
| GATA2 Transcription Factor | |
| Mice | |
| Trans-Activators | |
| Core Binding Factor Alpha 2 Subunit | |
| Proto-Oncogene Proteins | |
| Humans | |
| Chromatin | |
| Gene Expression Regulation | |
| Proto-Oncogene Protein Spi-1 |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 DK068634 | NIDDK NIH HHS | United States | R01DK068634 | PubMed |
Source NIH RePORTER
References82
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16236504 | Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK. | Bioorg Med Chem Lett | 2006 | https://conductscience.org/library/papers/16236504 | PubMed |
| 2 | 35924979 | The Impact of Inflammation-Induced Tumor Plasticity during Myeloid Transformation. | Cancer Discov | 2022 | https://conductscience.org/library/papers/35924979 | PubMed |
| 3 | 21330290 | FIMO: scanning for occurrences of a given motif. | Bioinformatics | 2011 | https://conductscience.org/library/papers/21330290 | PubMed |
| 4 | 25597637 | IRF8 acts in lineage-committed rather than oligopotent progenitors to control neutrophil vs monocyte production. | Blood | 2015 | https://conductscience.org/library/papers/25597637 | PubMed |
| 5 | 32269167 | IL-6 blockade reverses bone marrow failure induced by human acute myeloid leukemia. | Sci Transl Med | 2020 | https://conductscience.org/library/papers/32269167 | PubMed |
| 6 | 34233450 | The RUNX1 database (RUNX1db): establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy. | Haematologica | 2021 | https://conductscience.org/library/papers/34233450 | PubMed |
| 7 | 19470763 | Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development. | Mol Cell Biol | 2009 | https://conductscience.org/library/papers/19470763 | PubMed |
| 8 | 30707109 | Transcription factor mutations as a cause of familial myeloid neoplasms. | J Clin Invest | 2019 | https://conductscience.org/library/papers/30707109 | PubMed |
| 9 | 38422019 | Pathogenic GATA2 genetic variants utilize an obligate enhancer mechanism to distort a multilineage differentiation program. | Proc Natl Acad Sci U S A | 2024 | https://conductscience.org/library/papers/38422019 | PubMed |
| 10 | 32736380 | Constructing and deconstructing GATA2-regulated cell fate programs to establish developmental trajectories. | J Exp Med | 2020 | https://conductscience.org/library/papers/32736380 | PubMed |
| 11 | 24227816 | GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. | Blood | 2014 | https://conductscience.org/library/papers/24227816 | PubMed |
| 12 | 21670465 | Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. | Blood | 2011 | https://conductscience.org/library/papers/21670465 | PubMed |
| 13 | 18779319 | Molecular hallmarks of endogenous chromatin complexes containing master regulators of hematopoiesis. | Mol Cell Biol | 2008 | https://conductscience.org/library/papers/18779319 | PubMed |
| 14 | 34129017 | Innate immune pathways and inflammation in hematopoietic aging, clonal hematopoiesis, and MDS. | J Exp Med | 2021 | https://conductscience.org/library/papers/34129017 | PubMed |
| 15 | 1496401 | Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. | Science | 1992 | https://conductscience.org/library/papers/1496401 | PubMed |
| 16 | 12403772 | BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice. | J Biol Chem | 2003 | https://conductscience.org/library/papers/12403772 | PubMed |
| 17 | 21892162 | Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. | Nat Genet | 2011 | https://conductscience.org/library/papers/21892162 | PubMed |
| 18 | 21957195 | Functional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemia. | Blood | 2012 | https://conductscience.org/library/papers/21957195 | PubMed |
| 19 | 37522715 | ETV6 represses inflammatory response genes and regulates HSPC function during stress hematopoiesis in mice. | Blood Adv | 2023 | https://conductscience.org/library/papers/37522715 | PubMed |
| 20 | 22516264 | Altered microenvironmental regulation of leukemic and normal stem cells in chronic myelogenous leukemia. | Cancer Cell | 2012 | https://conductscience.org/library/papers/22516264 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42801378 | The Runx1-Gata2 axis: epigenetic architecture of lineage fate. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42801378 | PubMed |
| 41463011 | The Dual Role of RUNX1 in Inflammation-Driven Age-Related Diseases: From Molecular Mechanisms to Clinical Translation. | Biomedicines | 2025 | https://conductscience.org/library/papers/41463011 | PubMed |
| 41004342 | GATA2 decommissioning of enhancers: A mechanism to constrain inflammatory signaling. | Cell Rep | 2025 | https://conductscience.org/library/papers/41004342 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GATA2 | 2624 | PubTator's text mining | https://conductscience.org/library/genes/2624 | NCBI Gene |
| QRSL1 | 55278 | PubTator's text mining | https://conductscience.org/library/genes/55278 | NCBI Gene |
| RUNX1 | 861 | PubTator's text mining | https://conductscience.org/library/genes/861 | NCBI Gene |
| SPI1 | 6688 | PubTator's text mining | https://conductscience.org/library/genes/6688 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40435239
GET https://conductscience.org/api/papers/v1/40435239/references?page=2